British Journal of Clinical Pharmacology · 2007 · 55 citations · 24 references
Relative to the observed 16-fold variability in UGT1A1 activity, these data indicate only a partial (approximately 40%) contribution of the UGT1A1*28 polymorphism to variability of interindividual differences in UGT1A1 enzyme activity. For the UGT2B7*2 polymorphism, genotype had no influence on immunoreactive UGT2B7 protein or the rate of 3'-azido-3'-deoxythymidine glucuronidation.
24
Lalitha Iyer, Christopher D. King, P. F. Whitington et al. · Journal of Clinical Investigation · 1998 · 677 citations · Full text
Michael H. Court, Soundarajan Krishnaswamy, Qin Hao et al. · Drug Metabolism and Disposition · 2003 · 247 citations
C. Ramana Bhasker, Wendy McKinnon, Andrew N. Stone et al. · Pharmacogenetics · 2000 · 246 citations